BCAT | RORO | BCAT / RORO | |
Gain YTD | 15.270 | -5.331 | -286% |
Net Assets | 1.61B | 3.51M | 45,893% |
Total Expense Ratio | 1.99 | 1.14 | 175% |
Turnover | 257.00 | 1855.00 | 14% |
Yield | 3.04 | 4.01 | 76% |
Fund Existence | 5 years | 5 years | - |
BCAT | RORO | |
---|---|---|
RSI ODDS (%) | 4 days ago79% | 5 days ago83% |
Stochastic ODDS (%) | 4 days ago78% | 4 days ago77% |
Momentum ODDS (%) | 4 days ago90% | 4 days ago77% |
MACD ODDS (%) | 4 days ago90% | N/A |
TrendWeek ODDS (%) | 4 days ago85% | 4 days ago80% |
TrendMonth ODDS (%) | 4 days ago84% | 4 days ago82% |
Advances ODDS (%) | 4 days ago84% | 25 days ago77% |
Declines ODDS (%) | 12 days ago79% | 18 days ago80% |
BollingerBands ODDS (%) | 4 days ago84% | N/A |
Aroon ODDS (%) | 4 days ago85% | 4 days ago85% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MFWTX | 18.06 | -0.02 | -0.11% |
MFS Global Total Return A | |||
KMDIX | 31.99 | -0.08 | -0.25% |
Keeley Gabelli Mid Cap Dividend I | |||
RLEFX | 37.58 | -0.14 | -0.37% |
American Funds American Balanced R5E | |||
CRQSX | 14.01 | -0.09 | -0.64% |
Catholic Rspnsbl Invst Equity Idx Ins | |||
GSLLX | 23.52 | -0.18 | -0.76% |
Goldman Sachs Enhanced U.S. Equity Inv |
A.I.dvisor tells us that BCAT and MSFT have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BCAT and MSFT's prices will move in lockstep.
Ticker / NAME | Correlation To BCAT | 1D Price Change % | ||
---|---|---|---|---|
BCAT | 100% | +0.60% | ||
MSFT - BCAT | 10% Poorly correlated | -0.58% | ||
AMZN - BCAT | 3% Poorly correlated | -1.12% | ||
MA - BCAT | 2% Poorly correlated | +0.81% | ||
ASML - BCAT | 2% Poorly correlated | -2.73% | ||
GOOG - BCAT | 2% Poorly correlated | +0.55% |